Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Emerging biomarker technologies.

Laura Gunn¹, Martyn T Smith

¹Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley 94720-7360, USA.

IARC Scientific Publications

|April 2, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low-dose inorganic arsenic exposure reprograms macrophages differentiation and function toward tumor-promoting phenotypes.

Environmental research·2026

Same author

Long-term effect of early-life arsenic exposure on morning plasma cortisol in adults from Antofagasta, Chile.

Environmental health : a global access science source·2026

Same author

Proposed key characteristics of neurotoxic chemicals.

Neurotoxicology·2025

Same author

Long-Term Effect of Early-Life Arsenic Exposure on Morning Plasma Cortisol in Adults from Antofagasta, Chile.

medRxiv : the preprint server for health sciences·2025

Same author

Benzene Metabolism Is Dominated by a High-Affinity Pathway at Ambient Exposures with Implications for Cancer Risks.

International journal of molecular sciences·2025

Same author

Developmental Immunotoxicity of Low-dose Inorganic Arsenic Reprograms Macrophages Inducing Tumor-promoting Phenotypes.

bioRxiv : the preprint server for biology·2025

Same journal

North America.

IARC scientific publications·2016

Same journal

Central and South America.

IARC scientific publications·2016

Same journal

Africa.

IARC scientific publications·2016

Same journal

Data availability and presentation.

IARC scientific publications·2016

Same journal

Age standardization.

IARC scientific publications·2016

Same journal

Data processing.

IARC scientific publications·2016

See all related articles

New technologies like proteomics and nanotechnology offer powerful tools for identifying novel cancer risk biomarkers. These advancements complement genomics, but require validation through epidemiological studies.

Area of Science:

Biomarker Research
Molecular Epidemiology
Genomics and Proteomics

Background:

The human genome is highly variable, with numerous genes and functional polymorphisms.
High-throughput genomic technologies enable identification and analysis of gene mutations and polymorphisms.
Genomics alone is insufficient for identifying novel proteins and their functions.

Purpose of the Study:

To describe new technologies for molecular cancer epidemiology.
To discuss the potential of these technologies in cancer biomarker research.
To highlight the need for validation of new biomarkers in epidemiological studies.

Main Methods:

Review of emerging technologies including arrays, proteomics, and nanotechnology.
Discussion of their application in high-throughput, sensitive functional assays.

Related Experiment Videos

Integration of genomic and proteomic approaches for biomarker discovery.

Main Results:

New technologies provide platforms for identifying novel proteins and molecular interactions.
These technologies complement existing genomic approaches.
Potential for discovering new biomarkers of cancer risk.

Conclusions:

Emerging technologies significantly enhance cancer biomarker research potential.
A combination of genomic and proteomic approaches is crucial for comprehensive biomarker discovery.
Extensive validation in epidemiological studies is essential for newly identified cancer biomarkers.